APA (7th ed.) Citation

Zhou, X., Yan, S., Ma, X., Zhu, H., Liu, B., Yang, X., . . . Li, N. (2025). Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer. European Journal of Nuclear Medicine & Molecular Imaging, 52(7), 2343. https://doi.org/10.1007/s00259-025-07115-3

Chicago Style (17th ed.) Citation

Zhou, Xin, et al. "Efficacy of Radiolabelled PD-L1-targeted Nanobody in Predicting and Evaluating the Combined Immunotherapy and Chemotherapy for Resectable Non-small Cell Lung Cancer." European Journal of Nuclear Medicine & Molecular Imaging 52, no. 7 (2025): 2343. https://doi.org/10.1007/s00259-025-07115-3.

MLA (9th ed.) Citation

Zhou, Xin, et al. "Efficacy of Radiolabelled PD-L1-targeted Nanobody in Predicting and Evaluating the Combined Immunotherapy and Chemotherapy for Resectable Non-small Cell Lung Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 7, 2025, p. 2343, https://doi.org/10.1007/s00259-025-07115-3.